Eltropag (Tablet 50 mg)

Eltropag tablet is indicated for- Treatment of thrombocytopenia in patients with persistent or chronic immune thrombocytopenia. Treatment of thrombocytopenia in patients with hepatitis C infection. Treatment of severe aplastic anemia. Limitations of use: Eltropag tablet is not indicated for the treatment of patients with myelodysplastic syndromes (MDS). Safety and efficacy have not been established in combination with direct-acting antiviral agents used without interferon for the treatment of chronic hepatitis C infection. * রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'

Add to cart